A Randomized, Open-Label, Phase II Study of Sipuleucel-T with Concurrent vs Sequential Administration of Enzalutamide in Men with Metastatic Castrate Resistant Prostate Cancer

Conditions

Prostate

What is the purpose of this trial?

This is a randomized, open-label study designed to assess the effects of sipuleucel-T when administered concurrently or sequentially with enzalutamide.


Participation Guidelines

Age:
Gender:
Male

Click here for detailed information about who can participate in this trial.


Sponsor:
Dendreon Corporation
Dates:
03/10/2014
Last Updated:
Study HIC#:
1312013161